ZL-1503 Suppresses Atopic Dermatitis
This is a news story, published by Yahoo Finance, that relates primarily to Zai Lab Limited news.
drug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
atopic dermatitis. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest bispecific antibody news, chronic inflammation news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
severe atopic dermatitisInsider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
•Health
Health
Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis

79% Informative
Zai Lab Limited is a commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in oncology, immunology, neuroscience, and infectious disease.
ZL-1503, a promising IL-13/IL-31R bispecific antibody, demonstrated the ability to suppress the inflammatory and pruritogenic (itch-causing) pathways in atopic dermatitis.
VR Score
76
Informative language
75
Neutral language
21
Article tone
formal
Language
English
Language complexity
63
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
4
Source diversity
1
Affiliate links
no affiliate links